company

MEDIPURE AS

1715 YVEN

Return on Equity
−5,41 %
Current Ratio
1,14
Debt-to-Equity Ratio
−1,14
Key figures (NOK)2022
Revenue98 000
Net Income6 000
Total Assets133 000
Total Equity−111 000
Income (NOK)2022
Revenue98 000
Expenditure83 000
Operating Profit15 000
Financial Income0
Financial Costs9 000
Financial Balance−9 000
Earnings Before Tax6 000
Tax0
Net Income6 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets133 000
Total Assets133 000
Total Retained Equity−141 000
Total Equity−111 000
Total Long-Term Debt127 000
Total Current Debt117 000
Total Equity and Debt133 000
Cash flow (NOK)2022
Sales Income98 000
Other Income0
Revenue98 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure83 000
Operating Profit15 000
Financial Income0
Financial Costs9 000
Financial Balance−9 000
Dividends0
Net Income6 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock61 000
Total Investments0
Cash, Bank37 000
Total Current Assets133 000
Total Assets133 000
Total Equity−111 000
Short-Term Group Debt0
Total Long-Term Debt127 000
Creditors45 000
Unpaid Taxes0
Dividends0
Other Current Debt72 000
Total Current Debt117 000
Total Equity and Debt133 000
Financial indicators2022
Return on Equity−5,41 %
Debt-to-Equity Ratio−1,14
Operating Profit Margin15,31 %
Current Ratio1,14
Quick Ratio2,38
Equity Ratio−0,83
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English